Title:
【発明の名称】C型肝炎ウイルスNS3プロテアーゼの阻害剤
Document Type and Number:
Japanese Patent JP2003525294
Kind Code:
A
Abstract:
The present invention relates to compounds of Formula (I):wherein A<1 >is methylene, ethylene or propylene group and A<2 >is N or CR<5>, or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HCV NS3 protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
More Like This:
| WO/2002/022137 | $g(b)-LACTAM ANALOGS AND USES THEREFOR |
| JP2018529714 | Compounds and combinations for the treatment of HIV |
| JP6700203 | Boronic acid derivatives and their therapeutic use |
Inventors:
Xiao Jun Zhang
Wei Han
Wei Han
Application Number:
JP2001564175A
Publication Date:
August 26, 2003
Filing Date:
February 28, 2001
Export Citation:
Assignee:
Bristol-Myers Squibb Pharma Company
International Classes:
A61K31/69; A61P1/16; A61P31/14; A61P43/00; C07D487/04; C07F5/02; C07F5/04; (IPC1-7): C07F5/04; A61K31/69; A61P1/16; A61P31/14; A61P43/00
Attorney, Agent or Firm:
Yoshikazu Tani (2 outside)